From the Canadian Press:
An injectable liquid that delivers tiny radioactive "smart bombs" directly to cancer cells is showing great promise in treating patients with some types of non-Hodgkin's lymphoma, Canadian doctors say.
The drug, described as a "liquid radiotherapy," caused tumour reduction in 80 per cent of patients whose non-Hodgkin's lymphoma either did not respond to traditional chemotherapy or had recurred, a U.S. clinical trial has shown. Thirty per cent of those patients achieved full remission. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment